Skip to main content
. 2009 Oct 23;88(1):66–73. doi: 10.2471/BLT.08.065722

Fig. 2.

Potential impact of hepatitis B VEMs and ADAP-VEMs on public health

ADAP-VEM, antiviral drug-associated potential vaccine escape mutants; Anti-HBs−ve, anti-hepatitis B surface antigen-negative; Anti-HBs+ve, anti-hepatitis B surface antigen-positive; HBV, hepatitis B virus; VEMs, vaccine escape mutants

Fig. 2